Lung cancer accounts for a relatively high proportion of malignant tumors. As the most
prevalent type of lung cancer, non-small cell lung cancer (NSCLC) is characterized by high …

Although various cancer therapies have been developed in the last decade, much of their
anti-tumor effects are restricted by the tumor microenvironment complexity, such as the …

The complex immunosuppressive tumour microenvironment (TME) and lack of tumour-
specific targets hinder the application of chimeric antigen receptor (CAR) T cells in the …

Lung cancer continues to be a malignant tumor with high mortality. Two obstacles interfere
with curative therapy of lung cancer:(i) poor diagnosis at the early stages, as symptoms are …

Nanomaterials that can mimic the activity of various enzymes have been studied extensively
in the biomedical field in recent years. Nanozymes offer better stability and economic value …

Artificial organelles are compartmentalized nanoreactors, in which enzymes or enzyme‐
mimic catalysts exhibit cascade catalytic activities to mimic the functions of natural …

Autologous T cells genetically engineered to express chimeric antigen receptor (CAR) have
shown promising outcomes and emerged as a new curative option for hematological …

Independent of tumor type and non‐invasive or minimally‐invasive feature, current physical
treatments including ultrasound therapy, microwave ablation (MWA), and radiofrequency …

Chimeric antigen receptor (CAR) T cell therapy has achieved unprecedented clinical
success against hematologic malignancies. However, the transition of CAR-T cell therapies …

Multimodal therapies have aroused great interest in tumor therapy due to their highly
effective antitumor effect. However, immune clearance limits the practical application of …